CFOO · XBRL financial data

China Foods Holdings financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (CFOO's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	1,013	361	354	158	233	328
Cost of revenue	597	122	243	94	179	298
Gross profit	417	239	111	64	54	30
General and administrative	729	691	501	465	503	424
Total operating expenses	887	696	504	469	510	429
Operating income (loss)	(471)	(456)	(393)	(405)	(456)	(399)
Interest income	3	—	—	—	—	—
Other income (expense)	—	—	—	0	1	0
Income tax expense (benefit)	8	7	1	—	1	—
Net income (loss)	(469)	(455)	(354)	(404)	(456)	(399)
Earnings per share, basic USD per share	(0.03)	(0.02)	(0.02)	(0.02)	(0.02)	(0.02)
Earnings per share, diluted USD per share	—	—	(0.02)	(0.02)	(0.02)	(0.02)
Weighted average shares, basic thousands of shares	17,526	20,252	20,252	20,252	20,252	20,252
Weighted average shares, diluted thousands of shares	—	—	20,252	20,252	20,252	20,252

Fiscal years (CFOO's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	1,006	609	382	175	39	10
Accounts receivable	—	—	5	39	—	—
Inventory	206	328	139	48	55	39
Prepaid and other current assets	—	139	75	67	303	108
Total current assets	1,334	1,436	600	350	399	163
Property and equipment, net	194	133	55	13	34	28
Right-of-use asset	—	351	20	—	—	20
Total assets	1,532	1,572	679	365	435	213
Accounts payable	8	—	8	—	—	—
Total current liabilities	697	926	662	756	1,286	1,481
Lease liability, non-current	—	246	—	—	—	10
Total liabilities	697	—	—	—	1,286	1,490
Accumulated deficit	(463)	(918)	(1,272)	(1,676)	(2,132)	(2,530)
Total stockholders' equity	835	401	17	(391)	(851)	(1,277)
Total liabilities and equity	1,532	1,572	679	365	435	213
Common shares outstanding (cover page) thousands of shares	20,252	20,252	20,252	20,252	20,252	20,252

Fiscal years (CFOO's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(469)	(455)	(354)	(404)	(456)	(399)
Net cash from operating activities	344	(439)	(172)	(297)	(354)	(389)
Purchases of property and equipment	75	27	—	1	23	—
Net cash from investing activities	(68)	(27)	23	(1)	(23)	—
Net cash from financing activities	46	50	(53)	95	246	389
Net change in cash	372	(397)	(228)	(207)	(136)	(29)

SIC 2833 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2833 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
China Foods Holdings	16	0	(94)*	20.3M	0.2 quarters	Q2 FY26 10-QJun 30, 2026
Mosaic ImmunoEngineering	0	not reported	(0)*	7.2M	0.6 quarters	Q2 FY26 10-QJun 30, 2026
Hepion Pharmaceuticals	1,629	not reported	(1,394)*	90.2M	1.2 quarters	Q2 FY26 10-QJun 30, 2026
Twinlab Consolidated Holdings	13	not reported	(907)*	259.1M	0.0 quarters	Q4 FY24 10-KDec 31, 2024
Regen BioPharma	0.2	59	(24)*	1.7B	0.0 quarters	Q3 FY26 10-QJun 30, 2026
Nutra Pharma	not reported	34	(251)*	7.2B	0.1 quarters	Q2 FY26 10-QJun 30, 2026
Evofem Biosciences	285	2,633	(3,140)*	132.5M	0.1 quarters	Q2 FY26 10-QJun 30, 2026
International Stem Cell	1,089	2,675	167*	8.0M	—	Q2 FY26 10-QJun 30, 2026
Emmaus Life Sciences	2,808	6,318	1,693*	70.2M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.